{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T02:44:50Z","timestamp":1786416290559,"version":"build-2736575974"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873611"],"award-info":[{"award-number":["81873611"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Immunoglobulin A nephropathy (IgAN) is a highly prevalent glomerular disease. The diagnosis potential of the gut microbiome in IgAN has not been fully evaluated. Gut microbiota, serum metabolites, and clinical phenotype help to further deepen the understanding of IgAN.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>Cohort studies were conducted in healthy controls (HC), patients of IgA nephropathy (IgAN) and non-IgA nephropathy (n_IgAN). We used 16S rRNA to measure bacterial flora and non-targeted analysis methods to measure metabolomics; we then compared the differences in the gut microbiota between each group. The random forest method was used to explore the non-invasive diagnostic value of the gut microbiome in IgAN. We also compared serum metabolites and analyzed their correlation with the gut\u00a0microbiome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The richness and diversity of gut microbiota were significantly different among IgAN, n_IgAN and HC patients. Using a random approach, we constructed the diagnosis model and analysed the differentiation between IgAN and n_IgAN based on gut microbiota. The area under the receiver operating characteristic curve for the diagnosis was 0.9899. The metabolic analysis showed that IgAN patients had significant metabolic differences compared with HCs. In IgAN, catechol, l-tryptophan, (1H-Indol-3-yl)-N-methylmethanamine, and pimelic acid were found to be enriched. In the correlation analysis, l-tryptophan, blood urea nitrogen and <jats:italic>Eubacterium coprostanoligenes<\/jats:italic> were positively correlated with each other.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study demonstrated changes in the gut microbiota and established models for the non-invasive diagnosis of IgAN from HC and n_IgAN. We further demonstrated a close correlation between the gut flora, metabolites, and clinical phenotypes of IgAN. These findings provide further directions and clues in the study of the mechanism of IgAN.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2022.1059692","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T14:52:55Z","timestamp":1670511175000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes"],"prefix":"10.3389","volume":"12","author":[{"given":"Yijun","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanzheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1681\/asn.2014030288","article-title":"Gut bacteria products prevent AKI induced by ischemia-reperfusion","volume":"26","author":"Andrade-Oliveira","year":"2015","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/asn.2010121220","article-title":"Colonic contribution to uremic solutes","volume":"22","author":"Aronov","year":"2011","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"B3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/s0272-6386(88)80035-0","article-title":"Mesangial IgA in IgA nephropathy arises from the mucosa","volume":"12","author":"B\u00e9n\u00e9","year":"1988","journal-title":"Am. J. Kidney Dis."},{"key":"B4","first-page":"694","article-title":"[Intercapillary deposits of IgA-IgG]","volume":"74","author":"Berger","year":"1968","journal-title":"J. d'urol. Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2215\/cjn.04730514","article-title":"Association of indoxyl sulfate with heart failure among patients on hemodialysis","volume":"10","author":"Cao","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxins10070300","article-title":"Impact of altered intestinal microbiota on chronic kidney disease progression","volume":"10","author":"Castillo-Rodriguez","year":"2018","journal-title":"Toxins"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2215\/cjn.04500511","article-title":"Clinical outcomes and predictors for ESRD and mortality in primary GN","volume":"7","author":"Chou","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"B9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/ndt\/gfu343","article-title":"The intestine-renal connection in IgA nephropathy","volume":"30","author":"Coppo","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.semnephrol.2018.05.020","article-title":"The gut-renal connection in IgA nephropathy","volume":"38","author":"Coppo","year":"2018","journal-title":"Semin. Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2012.08.019","article-title":"Targeting gut flora to prevent progression of hepatocellular carcinoma","volume":"58","author":"Darnaud","year":"2013","journal-title":"J. Hepatol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099006","article-title":"Microbiota and metabolome associated with immunoglobulin a nephropathy (IgAN)","volume":"9","author":"De Angelis","year":"2014","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0016-5085(94)90158-9","article-title":"Propionate-initiated changes in intracellular pH in rabbit colonocytes","volume":"107","author":"DeSoignie","year":"1994","journal-title":"Gastroenterology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.557368","article-title":"A comparative study of the gut microbiota associated with immunoglobulin a nephropathy and membranous nephropathy","volume":"10","author":"Dong","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00281-021-00871-y","article-title":"The mucosal immune system and IgA nephropathy","volume":"43","author":"Gesualdo","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1017\/s0007114508960918","article-title":"Effect of a prebiotic mixture on intestinal comfort and general wellbeing in health","volume":"100","author":"Goetze","year":"2008","journal-title":"Br. J. Nutr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000355393","article-title":"Activation of the interleukin-4\/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy","volume":"38","author":"He","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.668219","article-title":"Fecal bacteria implicated in biofilm production are enriched and associate to gastrointestinal symptoms in patients with APECED - a pilot study","volume":"12","author":"Hetem\u00e4ki","year":"2021","journal-title":"Front. Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.kint.2018.03.008","article-title":"Serum metabolites are associated with all-cause mortality in chronic kidney disease","volume":"94","author":"Hu","year":"2018","journal-title":"Kidney Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"10994","DOI":"10.1038\/s41598-020-67910-w","article-title":"Spectrum of biopsy proven renal diseases in central China: a 10-year retrospective study based on 34,630 cases","volume":"10","author":"Hu","year":"2020","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.kint.2021.04.026","article-title":"Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy","volume":"100","author":"Kano","year":"2021","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","article-title":"IgA nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nm0411-418","article-title":"An amino acid profile to predict diabetes","volume":"17","author":"Langenberg","year":"2011","journal-title":"Nat. Med."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/srep30673","article-title":"Alterations in the fecal microbiota of patients with HIV-1 infection: An observational study in a Chinese population","volume":"6","author":"Ling","year":"2016","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.kint.2019.08.022","article-title":"TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy","volume":"97","author":"Makita","year":"2020","journal-title":"Kidney Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1128\/aem.72.2.1027-1033.2006","article-title":"Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study","volume":"72","author":"Mueller","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00925","article-title":"Bifidobacteria and their role as members of the human gut microbiota","volume":"7","author":"O'Callaghan","year":"2016","journal-title":"Front. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.2215\/cjn.10871016","article-title":"Temporal and demographic trends in glomerular disease epidemiology in the southeastern united states 1986-2015","volume":"12","author":"O'Shaughnessy","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.841614","article-title":"Gut microbiome signatures are predictive of cognitive impairment in hypertension patients-a cohort study","volume":"13","author":"Qu","year":"2022","journal-title":"Front. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/1574-6976.12075","article-title":"The first 1000 cultured species of the human gastrointestinal microbiota","volume":"38","author":"Rajili\u0107-Stojanovi\u0107","year":"2014","journal-title":"FEMS Microbiol. Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11892-017-0841-z","article-title":"Intestinal microbiota in type 2 diabetes and chronic kidney disease","volume":"17","author":"Sabatino","year":"2017","journal-title":"Curr. Diabetes Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/ndt\/gfaa264","article-title":"High levels of gut-homing immunoglobulin a+ b lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin a nephropathy patients","volume":"36","author":"Sallustio","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"B33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","article-title":"Proteobacteria: microbial signature of dysbiosis in gut microbiota","volume":"33","author":"Shin","year":"2015","journal-title":"Trends Biotechnol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12882-021-02315-z","article-title":"Gut microbiota in immunoglobulin a nephropathy: a Malaysian perspective","volume":"22","author":"Sugurmar","year":"2021","journal-title":"BMC Nephrol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1172\/jci38468","article-title":"Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity","volume":"119","author":"Suzuki","year":"2009","journal-title":"J. Clin. Invest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.kint.2017.10.019","article-title":"IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis","volume":"93","author":"Suzuki","year":"2018","journal-title":"Kidney Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/b978-0-12-800100-4.00003-9","article-title":"The role of short-chain fatty acids in health and disease","volume":"121","author":"Tan","year":"2014","journal-title":"Adv. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"14056","DOI":"10.1073\/pnas.0706517104","article-title":"Identification of IRS-1 ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance","volume":"104","author":"Tremblay","year":"2007","journal-title":"Proc. Natl. Acad. Sci. United States America"},{"key":"B39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s10096-010-0888-0","article-title":"Heterogeneity of the humoral immune response following staphylococcus aureus bacteremia","volume":"29","author":"Verkaik","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s40168-021-01165-z","article-title":"Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia","volume":"9","author":"Vicentini","year":"2021","journal-title":"Microbiome"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1042\/cs20190171","article-title":"Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease","volume":"133","author":"Wang","year":"2019","journal-title":"Clin. Sci. (London Engl. 1979)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1128\/cmr.00008-07","article-title":"Bacteroides: the good, the bad, and the nitty-gritty","volume":"20","author":"Wexler","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"B43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"New Engl. J. Med."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00042","article-title":"Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in alzheimer's disease brain: A review","volume":"10","author":"Zhan","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107085","article-title":"Modifications of gut microbiota are associated with the severity of ig a nephropathy in the Chinese population","volume":"89","author":"Zhong","year":"2020","journal-title":"Int. Immunopharmacol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1059692\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T14:53:00Z","timestamp":1670511180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1059692\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":46,"alternative-id":["10.3389\/fcimb.2022.1059692"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.1059692","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,8]]},"article-number":"1059692"}}